Germline Genetic Testing for Gene Variants Associated With Breast Cancer in Individuals at High Breast Cancer Risk (CHEK2, ATM, and BARD1)

Immediately: Review current genetic testing workflows to ensure proper documentation of high breast cancer risk criteria for CHEK2, ATM, and BARD1 testing. Billing team should verify that genetic testing claims include appropriate medical necessity documentation showing patient meets high-risk criteria. Update encounter forms and EMR templates to capture family history and risk assessment documentation required for coverage determination.